<?xml version="1.0" encoding="UTF-8"?>
<p id="par0125">Demographic and clinical variables according to in-hospital death are shown in 
 <xref rid="tbl0005" ref-type="table">Table 1</xref> . Overall, 347 (64.4%) patients were males; median age was of 66 years (Interquartile range—IQR: 54–78); 448 (83.1%) were Caucasian; 111 (20.6%) had close contacts with subjects affected by COVID-19 disease, 56 (10.4%) were resident in long-term facilities. A total of 77 (14.3%) were obese (e.g. BMI &gt; 30 kg/m
 <sup>2</sup>); 65.5% suffered from at least one comorbidity: 250 (46.4%) suffered from hypertension, 95 (17.6%) from diabetes, 147 (27.3%) from cardiovascular disease. Median days from onset of symptoms to admission were 6 (IQR: 3–10). Fever was present in 86% of cases, dyspnoea in 55.7% and cough in 50.5%; in 16.9% non-respiratory symptoms were only present. At admission, 35 cases (6.5%) were affected by mild disease, with no radiological signs of pneumonia; in 242 patients (44.9%) the disease was moderate; in 244 patients (45.3%) the disease was severe and in 18 (3.6%) critical with high-grade respiratory distress. In half of the patients (262, 48.7%) the PO
 <sub>2</sub>/FO
 <sub>2</sub> was below 300 mmHg. A number of laboratory markers were elevated, indicating the presence of an ongoing infection: CRP, procalcitonin, leukocytes, lymphocytes, 
 <sc>d</sc>-dimer, CPK, LDH, ferritin.
</p>
